NLTX - Neoleukin Therapeutics EPS in-line
Neoleukin Therapeutics (NASDAQ:NLTX): Q2 GAAP EPS of -$0.27 in-line. Cash and cash equivalents of $164.2M Press Release
For further details see:
Neoleukin Therapeutics EPS in-lineLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Neoleukin Therapeutics Inc. |
| Stock Symbol: | NLTX |
| Market: | NYSE |
Get NLTX Alerts
News, Short Squeeze, Breakout and More Instantly...